![Nathan LiaBraaten](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Nathan LiaBraaten
Contatto Relazioni con gli Investitori presso
SUMMIT THERAPEUTICS INC.
Profilo
Nathan Michael LiaBraaten is Senior Director-Investor Relations at Summit Therapeutics, Inc. since 2024.
Former roles include Director-External Affairs at The University of Oregon Investment Group and Research Associate at Stonepine Capital Management LLC.
Education includes an undergraduate degree (2005) and an MBA (2006) from the University of Oregon.
Posizioni attive di Nathan LiaBraaten
| Società | Posizione | Inizio |
|---|---|---|
| SUMMIT THERAPEUTICS INC. | Contatto Relazioni con gli Investitori | 01/01/2024 |
Precedenti posizioni note di Nathan LiaBraaten
| Società | Posizione | Fine |
|---|---|---|
Stonepine Capital Management LLC
 Stonepine Capital Management LLC Investment ManagersFinance Stonepine aims to achieve superior absolute returns while preserving capital primarily by investing its assets in publicly traded healthcare companies. Their investment focus is companies with commercial stage products generating sustainable revenue and companies with substantial financial assets (such as cash and royalty income streams). The firm looks for companies whose valuations reflect a material discount to their fundamental value in the healthcare space. | Analyst-Equity | - |
The University of Oregon Investment Group
 The University of Oregon Investment Group Investment ManagersFinance UOIG utilizes tactics of fundamental equity valuation, actively manages two portfolios, and takes several educational trips throughout the year, they give its members an extremely valuable and unique opportunity to explore finance. The firm utilizes two primary quantitative valuation methods in order to estimate the intrinsic value of a company: Comparables Analysis and Discounted Cash Flows Analysis (DCF). | Analyst-Equity | - |
Formazione di Nathan LiaBraaten
Esperienze
Posizioni ricoperte
Attive
Inattive
Società nel listino
Aziende private
Relazioni
79
Relazioni di 1° grado
4
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Aziende private | 4 |
|---|---|
Stonepine Capital Management LLC
Stonepine Capital Management LLC Investment ManagersFinance Stonepine aims to achieve superior absolute returns while preserving capital primarily by investing its assets in publicly traded healthcare companies. Their investment focus is companies with commercial stage products generating sustainable revenue and companies with substantial financial assets (such as cash and royalty income streams). The firm looks for companies whose valuations reflect a material discount to their fundamental value in the healthcare space. | Finance |
The University of Oregon Investment Group
The University of Oregon Investment Group Investment ManagersFinance UOIG utilizes tactics of fundamental equity valuation, actively manages two portfolios, and takes several educational trips throughout the year, they give its members an extremely valuable and unique opportunity to explore finance. The firm utilizes two primary quantitative valuation methods in order to estimate the intrinsic value of a company: Comparables Analysis and Discounted Cash Flows Analysis (DCF). | Finance |
University of Oregon
 University of Oregon Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Summit Therapeutics, Inc.
 Summit Therapeutics, Inc. BiotechnologyHealth Technology Develops biopharmaceutical products | Health Technology |
